The National Hemophilia Foundation (NHF) and Takeda have teamed up to launch a series of PSAs and resources that hope to increase the awareness of von Willebrand disease (VWD). The PSAs feature Alex Borstein, Emmy-award winning actress, writer, and…
At the National Hemophilia Foundation’s (NHF) Bleeding Disorders Conference, held virtually this year, NHF president and CEO Leonard Valentino, MD, asked each person to consider their purpose. “When I think about why I go to work every day, the…
The National Hemophilia Foundation is thrilled to highlight several exciting, certified educational offerings for physicians, nurses and social workers at the upcoming 72nd Bleeding Disorders Conference (BDC). The following sessions, plus the entire…
The National Hemophilia Foundation would like to invite all healthcare providers attending NHF’s Virtual Bleeding Disorder Conference, to join us this Saturday, August 1st, for the Second Annual Victor Grifols Roura Medical Preconference…
It is well established that the clinical management of pregnant women with congenital bleeding disorders (CBDs) is challenging, as healthcare providers, including obstetricians, hematologists and other specialists must consider potential varying…
Immediately following the issuance of medical advisories to the community regarding the recall of Stimate® (desmopressin nasal spray ) a product used to control bleeding in patients with von Willebrand disease and hemophilia A, the National…
Objective:
People with hemophilia (PWH) commonly self-infuse at home, and can provide valuable insights into device attributes. While Novo Nordisk initially launched recombinant activated FVII (NovoSeven® RT) with vial adaptors,…
Ferring Pharmaceuticals Inc. is initiating a precautionary voluntary recall of all batches of Stimate® Nasal Spray (desmopressin acetate) 1.5 mg/mL. During testing of a sample of desmopressin acetate nasal spray solution product marketed outside the…
The National Hemophilia Foundation will be hosting a dynamic set of public health sessions as part of the upcoming Virtual Bleeding Disorders Conference (BDC). The product of an exciting collaboration between NHF and several national blood disorder…
Recently, there has been considerable interest in the role von Willebrand Factor (VWF) may play in the complications of COVID-19, the infection caused by SARS-CoV-2, including in lay online media.
The SARS-CoV-2 virus attaches to the cells that…